Director Peter K. Honig resigns from Karyopharm board, effective Dec 31, 2023

Karyopharm Therapeutics Inc.

Peter K. Honig, M.D., MPH, resigns from Board of Directors effective Dec 31, 2023.
Departure due to competing professional demands; no disagreement with the Company.
No replacement announced; resignation reduces board size.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Peter K Honig

member of the Board of Directors

KPTI · Karyopharm Therapeutics Inc.

Effective: 2023-12-31
Filed: December 8, 2023, 6:59 PM ET

On December 5, 2023, Peter K Honig, M.D., MPH, a member of the Board of Directors (the “Board”) of Karyopharm Therapeutics Inc. (the “Company”), notified the Company of his resignation from the Board, effective as of December 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter K Honig resigned as member of the Board of Directors at Karyopharm Therapeutics Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On December 5, 2023, Peter K Honig, M.D., MPH, a member of the Board of Directors (the “Board”) of Karyopharm Therapeutics Inc. (the “Company”), notified the Company of his resignation from the Board, effective as of December 31, 2023.

View on SEC.gov

Karyopharm Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-291208

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.